首页> 外文期刊>Obstetrics and Gynecology: Journal of the American College of Obstetricians and Gynecologists >Treatment of metastatic gestational choriocarcinoma with oral methotrexate in a combat environment.
【24h】

Treatment of metastatic gestational choriocarcinoma with oral methotrexate in a combat environment.

机译:在作战环境中口服甲氨蝶呤治疗转移性妊娠绒毛膜癌。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Gestational trophoblastic neoplasia (GTN) is a rare neoplastic complication of pregnancy. This disease can be successfully treated with parenteral intravenous or intramuscular chemotherapy. We present a case of metastatic gestational choriocarcinoma following a term pregnancy that was treated successfully with oral methotrexate therapy. CASE: A 25-year-old, G4 P4, native Afghani with a history of irregular menses since the birth of her son 6 months ago received a physical examination that was within normal limits. Pelvic examination revealed minimal blood in the vault and slight bleeding from a closed cervical os. The uterus was slightly enlarged, 5 weeks in size, and without any adnexal masses. Laboratory evaluation was significant for a positive urine and serum beta-HCG. Pelvic ultrasound examination revealed a 5-cm uterus with a 2-cm endometrial stripe. Chest radiograph revealed multiple bilateral ill-defined pulmonary nodules confirmed by computerized tomography. The patient underwent dilation and curettage productive of a moderate amount of tissue. The patient continued to have positive serum beta-HCGs and was given the presumptive diagnosis of FIGO stage III gestational choriocarcinoma. Because of the lack of intravenous chemotherapeutic agents, the patient was begun on methotrexate 0.40 mg/kg orally on days 1-5, with 9 days off. The patient completed one course of chemotherapy, followed by an interval total abdominal hysterectomy with bilateral salpingo-oophorectomy. The patient had a complete response to therapy and was treated with oral methotrexate for 2 courses after a negative serum beta-HCG. The patient tolerated the chemotherapy without any complication. CONCLUSION: Methotrexate is routinely used in a parenteral intramuscular fashion for the treatment of gestational choriocarcinoma. Physicians should be aware that, in very limited situations, oral methotrexate in combination with hysterectomy still could offer a patient successful treatment for stage III GTN.
机译:背景:妊娠滋养细胞肿瘤(GTN)是一种罕见的妊娠肿瘤并发症。该疾病可以通过肠胃外静脉内或肌肉内化学疗法成功治疗。我们介绍了足月妊娠后经口服甲氨蝶呤治疗成功治疗的转移性妊娠绒毛膜癌。案例:一名25岁,G4 P4的阿富汗裔本地人,自从她的儿子六个月前出生以来就具有月经不调的病史,接受了体检,且身体检查在正常范围内。盆腔检查发现穹ault内血液极少,闭合的宫颈口腔有少量出血。子宫略大,大小为5周,没有任何附件包块。实验室评估对于尿液和血清β-HCG阳性非常重要。盆腔超声检查显示子宫长5厘米,子宫内膜条纹2厘米。胸部X光片显示计算机断层扫描证实了多个双侧不明确的肺结节。患者进行了扩张和刮宫,产生了适量的组织。患者继续具有血清β-HCG阳性,并被假定诊断为FIGO III期妊娠绒毛膜癌。由于缺乏静脉化疗药物,该患者在1-5天开始口服甲氨蝶呤0.40 mg / kg,停药9天。患者完成了一个疗程的化学疗法,随后进行了全腹子宫全切除术和双侧输卵管卵巢切除术。病人对治疗完全反应,血清β-HCG阴性后接受口服甲氨蝶呤治疗2个疗程。患者耐受化疗,无任何并发症。结论:甲氨蝶呤通常以肠胃外肌内方式用于治疗妊娠绒毛膜癌。医师应意识到,在非常有限的情况下,口服甲氨蝶呤联合子宫切除术仍可为患者成功地治疗III期GTN。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号